InvestorsHub Logo

Drugdoctor

12/19/22 9:25 AM

#19099 RE: StevenRisk #19098

Agree, I applaud the all cash acquisitions, and opening new locations approach they have used recently, causing no new debt or dilution to the stock.

I think the pace of acquisition could accelerate in 2023, as possible one of the larger players in the states they are operating in, could decide to consolidate their operations into other states, and sell a quantity of stores to Schwazze at a really good price.

With the dispensary price down to around 1 million dollars now, 40 million dollars would acquire 40 more dispensaries! Any way, it's nice to see steady measured growth... We have a winner here.